Clinical Trials in Seattle

Showing 4841-4860 of 9,312 trials

CMX001 in Post-transplant Patients With BK Virus Viruria

NCT00793598

This was a randomized, double-blind, multiple-dose placebo-controlled study of oral brincidofovir (BCV) in hematopoietic stem cell transplant and renal transplant recipients with BK virus viruria.

Viruria

Jazz Pharmaceuticals29 participantsStarted Nov 2009

San Francisco, California, United States • San Francisco, California, United States • Chicago, Illinois, United States +12 more locations

COMPLETEDPhase 2< 1 mile

Open-Label, Safety and Tolerability Extension Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS) (CL211)

NCT00931944

This is an open-label, multi-center study designed to extend the evaluation of the safety, tolerability, and clinical effects of oral administration of KNS-760704 in patients with ALS.

Amyotrophic Lateral Sclerosis

Knopp Biosciences74 participantsStarted Jul 2009

Little Rock, Arkansas, United States • Los Angeles, California, United States • San Francisco, California, United States +16 more locations

CMX001 in Post-transplant Patients With BK Virus Viruria

Open-Label, Safety and Tolerability Extension Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS) (CL211)

Find Trials by Condition in Seattle

Study to Assess the Safety and Efficacy of Brincidofovir in Treatment of Early Versus Late Adenovirus Infection

Dose-Finding Study of Oral Ibrexafungep (SCY-078) vs. Oral Fluconazole in Subjects With Acute Vulvovaginal Candidiasis

Evaluation of mHealth for Serious Mental Illness

Pilot of Cohort of Households for Influenza Monitoring and Evaluation in Seattle

Docetaxel and Carboplatin for Patients With mCRPC and DNA-Repair Deficiencies

Sleep Intervention for Kids and Parents: A Self-Management Pilot Study

Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy (ART)

Telmisartan to Reduce AIDS-Related Fibrotic and Inflammatory Contributors (TRAFIC Study)

A Study To Investigate Tanezumab In Patients With Interstitial Cystitis/ Painful Bladder Syndrome

A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors

A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients

A Double Blind, Randomized, Controlled Study to Evaluate CHF 5633 (Synthetic Surfactant) and Poractant Alfa in Neonates With Respiratory Distress Syndrome (RDS) (POC)

Evaluation of Geistlich Fibro-Gide® + CAF in Comparison to CTG + CAF for the Treatment of Recession Defects at 6 Months

Study to Evaluate the Safety and Efficacy of Relamorelin in Participants With Diabetic Gastroparesis Study 02

A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease

Open Label, Phase III Study of NABI-IGIV 10% [Immune Globulin Intravenous(Human), 10%] In Subjects With Primary Immune Deficiency Disorders (PIDD)

Study to Evaluate the Safety and Efficacy of JTE-051 in Subjects With Moderate to Severe Plaque Psoriasis

Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias